Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-04-13
1988-09-13
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142305, 544 52, 544105, A61K 31535, A61K 3154, C07D26536, C07D27916
Patent
active
047710500
ABSTRACT:
Compounds of the general formula: ##STR1## wherein, R.sup.1 and R.sup.2 are, the same or different, hydrogen, a halogen, a lower alkyl, a cycloalkyl, a lower alkoxy, trifluoromethyl or a phenylalkyloxy whose phenyl ring may be substituted by one to three substituents selected from the group consisting of a halogen, a lower alkyl, a lower alkoxy, methylenedioxy and trifluoromethyl; R.sup.3 is hydrogen or methyl; R.sup.4 is carboxyl or an esterified carboxyl; and X is oxygen or sulfur, or a salt thereof. These compounds possess aldose reductase inhibitory and platelet aggregation inhibitory activities, and are of use as drugs for prevention and treatment of diabetic complications such as diabetic cataract, retinophathy, nephropathy, and neuropathy.
Ikeda Hitoshi
Meguro Kanji
Yamamoto Yujiro
Raymond Richard L.
Senju Pharmaceutical Co. Ltd.
Takeda Chemical Industries Ltd.
LandOfFree
Thiolactam-n-acetic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiolactam-n-acetic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiolactam-n-acetic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-807129